Elevance Health Sees FY2024 Adj EPS $33.00 vs $37.26 Est
Portfolio Pulse from Benzinga Newsdesk
Elevance Health has announced its FY2024 adjusted EPS guidance of $33.00, which is below the analyst estimate of $37.26.
October 17, 2024 | 10:04 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Elevance Health's FY2024 adjusted EPS guidance of $33.00 is significantly below the analyst estimate of $37.26, which may lead to a negative market reaction.
The company's guidance for FY2024 adjusted EPS is lower than what analysts expected, which typically results in a negative reaction from investors as it suggests lower profitability than anticipated.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100